These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32299489)

  • 1. Mitochondrial respiratory chain deficiency correlates with the severity of neuropathology in sporadic Creutzfeldt-Jakob disease.
    Flønes IH; Ricken G; Klotz S; Lang A; Ströbel T; Dölle C; Kovacs GG; Tzoulis C
    Acta Neuropathol Commun; 2020 Apr; 8(1):50. PubMed ID: 32299489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsied case of MM1 + MM2-cortical with thalamic-type sporadic Creutzfeldt-Jakob disease presenting with hyperintensities on diffusion-weighted MRI before clinical onset.
    Iwasaki Y; Mori K; Ito M; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Feb; 37(1):78-85. PubMed ID: 27436355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau pathology in Creutzfeldt-Jakob disease revisited.
    Kovacs GG; Rahimi J; Ströbel T; Lutz MI; Regelsberger G; Streichenberger N; Perret-Liaudet A; Höftberger R; Liberski PP; Budka H; Sikorska B
    Brain Pathol; 2017 May; 27(3):332-344. PubMed ID: 27377321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B; Blanco R; Martí E
    Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial correlation between the vacuolation, prion protein, deposition and surviving neurons in patients with Creutzfeldt-Jakob disease (vCJD).
    Armstrong RA; Lantos PL; Ironside JW; Cairns NJ
    J Neural Transm (Vienna); 2003 Nov; 110(11):1303-11. PubMed ID: 14628194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronological Changes in the Expression Pattern of Hippocampal Prion Proteins During Disease Progression in Sporadic Creutzfeldt-Jakob Disease MM1 Subtype.
    Yagita K; Noguchi H; Koyama S; Hamasaki H; Komori T; Aishima S; Kosaka T; Ueda M; Komohara Y; Watanabe A; Sasagasako N; Ninomiya T; Oda Y; Honda H
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):900-909. PubMed ID: 36063412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
    Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter involvement in sporadic Creutzfeldt-Jakob disease.
    Caverzasi E; Mandelli ML; DeArmond SJ; Hess CP; Vitali P; Papinutto N; Oehler A; Miller BL; Lobach IV; Bastianello S; Geschwind MD; Henry RG
    Brain; 2014 Dec; 137(Pt 12):3339-54. PubMed ID: 25367029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease.
    Zafar S; Younas N; Sheikh N; Tahir W; Shafiq M; Schmitz M; Ferrer I; Andréoletti O; Zerr I
    Mol Neurobiol; 2018 May; 55(5):4009-4029. PubMed ID: 28573459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
    Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
    Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
    Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the vacuolation (spongiform change) and prion protein deposition in 11 patients with sporadic Creutzfeldt-Jakob disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Acta Neuropathol; 2001 Dec; 102(6):591-6. PubMed ID: 11761719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-specific synaptic proteome alterations in sporadic Creutzfeldt-Jakob disease.
    Gawinecka J; Nowak M; Carimalo J; Cardone F; Asif AR; Wemheuer WM; Schulz-Schaeffer WJ; Pocchiari M; Zerr I
    J Alzheimers Dis; 2013; 37(1):51-61. PubMed ID: 23780662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.
    Tahir W; Zafar S; Llorens F; Arora AS; Thüne K; Schmitz M; Gotzmann N; Kruse N; Mollenhauer B; Torres JM; Andréoletti O; Ferrer I; Zerr I
    Mol Neurobiol; 2018 Jan; 55(1):517-537. PubMed ID: 27975168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autopsied case of sporadic Creutzfeldt-Jakob disease classified as MM1+2C-type.
    Iwasaki Y; Kato H; Ando T; Akagi A; Mimuro M; Miyahara H; Kobayashi A; Kitamoto T; Yoshida M
    Neuropathology; 2019 Jun; 39(3):240-247. PubMed ID: 31062411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease.
    Pascuzzo R; Oxtoby NP; Young AL; Blevins J; Castelli G; Garbarino S; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Alexander DC; Bizzi A
    Acta Neuropathol; 2020 Aug; 140(2):169-181. PubMed ID: 32535770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gene transcription linked to astrocytes and oligodendrocytes in frontal cortex in Creutzfeldt-Jakob disease.
    Andres Benito P; Dominguez Gonzalez M; Ferrer I
    Prion; 2018; 12(3-4):216-225. PubMed ID: 30009661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.